Death Receptor 6 and Caspase-6 Regulate Prion Peptide-Induced Axonal Degeneration in Rat Spinal Neurons

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Molecular Neuroscience

• Publication date

  2015-04-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12031-015-0562-1PMID 25898930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis

  2013cited by this paper
• Distinct Pathways Mediate Axon Degeneration during Apoptosis and Axon-Specific Pruning

  2013cited by this paper
• A DR6/p75NTR complex is responsible for β-amyloid-induced cortical neuron death

  2013influential reference
• Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions

  2013cited by this paper
• A Caspase Cascade Regulating Developmental Axon Degeneration

  2012cited by this paper
• Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice.

  2012cited by this paper
• The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation

  2012cited by this paper
• Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination

  2011cited by this paper
• Amyloid Precursor Protein Cleavage-Dependent and -Independent Axonal Degeneration Programs Share a Common Nicotinamide Mononucleotide Adenylyltransferase 1-Sensitive Pathway

  2010influential reference
• Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

  2009cited by this paper
• Microtubule assembly, organization and dynamics in axons and dendrites

  2009cited by this paper
• APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

  2009cited by this paper
• Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology.

  2009cited by this paper
• PrP(106-126) does not interact with membranes under physiological conditions.

  2008cited by this paper
• Signaling by death receptors in the nervous system.

  2008cited by this paper
• Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease*S

  2008cited by this paper
• Amyloid fibrils of mammalian prion protein induce axonal degeneration in NTERA2‐derived terminally differentiated neurons

  2007cited by this paper
• Mechanisms of axon degeneration: from development to disease.

  2007cited by this paper
• Dendritic Pathology in Prion Disease Starts at the Synaptic Spine

  2007cited by this paper
• Adaptive roles of programmed cell death during nervous system development.

  2006cited by this paper
• Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human*

  2006cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• Axon retraction and degeneration in development and disease.

  2005cited by this paper
• Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.

  2004cited by this paper
• Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease

  2004cited by this paper
• Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation

  2003cited by this paper
• Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease

  2003cited by this paper
• Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system.

  2003cited by this paper
• Axonal damage: a key predictor of outcome in human CNS diseases.

  2003cited by this paper
• Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.

  2003cited by this paper
• NuMA and nuclear lamins behave differently in Fas-mediated apoptosis

  2003cited by this paper
• Axon pathology in neurological disease: a neglected therapeutic target.

  2002cited by this paper
• Axonal Self-Destruction and Neurodegeneration

  2002influential reference
• Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice

  2001cited by this paper
• Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus

  2000cited by this paper
• Apoptosis signaling by death receptors.

  1998cited by this paper
• Identification and functional characterization of DR6, a novel death domain‐containing TNF receptor

  1998cited by this paper
• Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease

  1995cited by this paper
• Scrapie pathogenesis.

  1993cited by this paper
• Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.

  1993cited by this paper
• Neurotoxicity of a prion protein fragment

  1993cited by this paper
• Molecular biology of prion diseases

  1991influential reference

• The Intricate Role of Caspase-6 and Death Receptor-6 in Neurodegenerative Diseases.

  2025cites this paper
• Death receptor 6 does not regulate axon degeneration and Schwann cell injury responses during Wallerian degeneration

  2025cites this paper
• DR6 Augments Colorectal Cancer Cell Growth, Invasion, and Stemness by Activating AKT/NF-κB Pathway

  2024cites this paper
• SARM1 participates in axonal degeneration and mitochondrial dysfunction in prion disease

  2022influential citation
• Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo

  2022cites this paper
• Interlacing the relevance of caspase activation in the onset and progression of Alzheimer's Disease.

  2022cites this paper
• A Structural and Functional Perspective of Death Receptor 6

  2022cites this paper
• Mitochondrial Behavior in Axon Degeneration and Regeneration

  2021cites this paper
• Silencing of circFoxO3 Protects HT22 Cells from Glutamate-Induced Oxidative Injury via Regulating the Mitochondrial Apoptosis Pathway

  2020cites this paper
• Proapoptotic Mitochondrial Carrier Homolog Protein PSAP Mediates Death Receptor 6 Induced Apoptosis

  2020cites this paper
• Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice

  2020cites this paper
• CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage

  2020cites this paper
• IL-22 hinders antiviral T cell responses and exacerbates ZIKV encephalitis in immunocompetent neonatal mice

  2020cites this paper
• MicroRNA‐219 decreases hippocampal long‐term potentiation inhibition and hippocampal neuronal cell apoptosis in type 2 diabetes mellitus mice by suppressing the NMDAR signaling pathway

  2019cites this paper
• Polyornithine-based polyplexes to boost effective gene silencing in CNS disorders.

  2019cites this paper
• Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury

  2018cites this paper
• Therapeutic opportunities and pitfalls in the treatment of axon degeneration

  2018cites this paper
• The Molecular Interplay between Axon Degeneration and Regeneration

  2018cites this paper
• Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases

  2018cites this paper
• NAD+: A key metabolic regulator with great therapeutic potential

  2017cites this paper
• Alteration in the relationship between tanycytes and gonadotrophin‐releasing hormone neurosecretory terminals following long‐term metabolic manipulation in the sheep

  2017cites this paper
• This item is the archived peer-reviewed author-version of: Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in LRSAM1 Reference:

  2017cites this paper
• Role of the AMPK pathway in promoting autophagic flux via modulating mitochondrial dynamics in neurodegenerative diseases: Insight into prion diseases.

  2017cites this paper
• PRAS40 alleviates neurotoxic prion peptide‐induced apoptosis via mTOR‐AKT signaling

  2017cites this paper
• A central role for calcineurin in protein misfolding neurodegenerative diseases

  2016cites this paper